Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy,…
Imfinzi plus Lynparza reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer Positive results from the primary analysis of the DUO-E…
Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) The approval by the National Medical Products Administration (NMPA) in China was based on results…
FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents Pfizer Inc. (NYSE: PFE) announced today that the…
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced results from the global Phase 2 DeLLphi-301 study, evaluating tarlatamab, an investigational delta-like ligand 3 (DLL3) targeting…
AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023 Amgen (NASDAQ:AMGN) today announced that it will host a webcasted call for the investment community at 8:00 a.m. ET on Tuesday, Oct. 24, 2023 following the presentation…
Sanofi delivers first medicines from Global Health Unit’s Impact brand portfolio Sanofi has delivered the first medicines from its Global Health Unit’s not-for-profit Impact brand portfolio to the Republic of…
Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program Gilead Sciences, Inc. (Nasdaq: GILD) today announced PURPOSE 5, the…
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative…
REGENERON BUILDS ON TOGETHER FOR CHANGE™ INITIATIVE WITH FIVE-YEAR, $5 MILLION COMMITMENT TO FUEL THE STEM TALENT PIPELINE IN NASHVILLE, TN TARRYTOWN, N.Y., Oct. 18, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today…
TOGETHER FOR CHANGE GENOMICS AND EQUITY INITIATIVE LAUNCHED BY A COALITION OF MEHARRY MEDICAL COLLEGE, REGENERON GENETICS CENTER, ASTRAZENECA, NOVO NORDISK, AND ROCHE TO IMPROVE HEALTH OUTCOMES FOR PEOPLE OF…
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD Takeda (TSE:4502/NYSE:TAK) today announced that the European…